Published online Mar 9, 2024. doi: 10.5492/wjccm.v13.i1.88385
Peer-review started: September 23, 2023
First decision: November 9, 2023
Revised: December 4, 2023
Accepted: January 5, 2024
Article in press: January 5, 2024
Published online: March 9, 2024
Processing time: 164 Days and 4.8 Hours
Driving pressure (∆P) is a core therapeutic component of mechanical ventilation (MV). Varying levels of ∆P have been employed during MV depending on the type of underlying pathology and severity of injury. However, ∆P levels have also been shown to closely impact hard endpoints such as mortality. Considering this, conducting an in-depth review of ∆P as a unique, outcome-impacting therapeutic modality is extremely important. There is a need to understand the subtleties involved in making sure ∆P levels are optimized to enhance outcomes and minimize harm. We performed this narrative review to further explore the various uses of ∆P, the different parameters that can affect its use, and how outcomes vary in different patient populations at different pressure levels. To better utilize ∆P in MV-requiring patients, additional large-scale clinical studies are needed.
Core Tip: Driving pressures (∆P) of < 15 have demonstrated the greatest benefit in mortality. It is most utilized in patients with acute respiratory distress syndrome (ARDS). Some large-scale randomized controlled trials are currently underway; their results will dictate the outcomes of certain ∆Ps under specialized conditions, such as the feasibility of reducing ∆P in ARDS patients on mechanical ventilation and the impact of lateral positioning on ∆P. It is clear, however, that careful implementation of ∆Ps can greatly improve outcomes.
